Healthcare Finance News May 13, 2022
Controlling COVID-19 globally requires the most vulnerable to have access to lifesaving treatments, says HHS Secretary Xavier Becerra.
The National Institutes of Health has announced an agreement with the World Health Organization and the Medicines Patent Pool to make COVID-19 health technologies available worldwide.
The NIH has licensed 11 COVID-19 research tools and early-stage vaccine and diagnostic candidates to the Medicines Patent Pool through WHO’s COVID-19 Technology Access Pool, or C-TAP.
The licenses will allow manufacturers from all around the world to use these technologies for the potential development of COVID-19 vaccines, treatments and diagnostics to benefit people living in low- and middle-income countries. Included in the technologies licensed is the SARS-CoV-2 stabilized spike protein – a patented...
Today's Sponsors
Today's Sponsor